Interleukin-1 Receptor Antagonist Polymorphism in Patients with Prostate Cancer and Benign Prostatic Hyperplasia: A Case Control Study from North India

Author： Mittal R.D.   Mishra D.K.   Bid H.K.   Mandhani A.  

Publisher： Ashgate Publishing Ltd

ISSN： 1561-0950

Source： UroOncology, Vol.4, Iss.3-4, 2004-09, pp. : 131-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

By Osman Nadir I   Chapple Christopher R   Cruz Francisco   Desgrandchamps François   Llorente Carlos   Montorsi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2085-2096

Informa Healthcare

Access to resources Recommend Favorite

Potential Efficacy of Some African Plants in Benign Prostatic Hyperplasia and Prostate Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-10 ,pp. : 1564-1571

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India

By Srivastava Daya   Kumar Anant   Mittal Balraj   Mittal Rama  

Archives of Toxicology, Vol. 78, Iss. 8, 2004-08 ,pp. : 430-434

Springer Publishing Company

Access to resources Recommend Favorite

Silodosin, a novel selective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia

By Yoshida Masaki   Homma Yukio   Kawabe Kazuki  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1955-1965

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Benign Prostatic Hyperplasia in Patients with Cardiovascular Disease

By Santillo Vincent M.   Lowe Franklin C.  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 795-805

Adis International

Access to resources Recommend Favorite